Ouro Fino Saúde Animal Participações S.A Market Cap ($269.03 Million)
Market Cap & Net Worth: Ouro Fino Saúde Animal Participações S.A (OFSA3)
Ouro Fino Saúde Animal Participações S.A market cap. Ouro Fino Saúde Animal Participações S.A (SA:OFSA3) has a market capitalization of $269.03 Million (R$1.37 Billion) as of October 30, 2026. Listed on the SA stock exchange, this Brazil-based company holds position #15161 globally and #144 in its home market, demonstrating a -15.84% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Ouro Fino Saúde Animal Participações S.A's stock price R$25.50 by its total outstanding shares 53767606 (53.77 Million).
Ouro Fino Saúde Animal Participações S.A Market Cap History (2015–2026)
Ouro Fino Saúde Animal Participações S.A market cap history from 2015 to 2026. Data shows change from $325.27 Million to $269.03 Million (-1.66% CAGR). Check Ouro Fino Saúde Animal Participações S.A stock quote for real-time trading data and today's change.
Ouro Fino Saúde Animal Participações S.A Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Ouro Fino Saúde Animal Participações S.A's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Also see how efficiently does Ouro Fino Saúde Animal Participações S.A generate cash for how efficiently the company converts equity into cash flow.
Latest Price to Sales (P/S) Ratio
0.20x
Ouro Fino Saúde Animal Participações S.A's market cap is 0.20 times its annual revenue
Latest Price to Earnings (P/E) Ratio
1.09x
Ouro Fino Saúde Animal Participações S.A's market cap is 1.09 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $261.59 Million | $456.59 Million | -$5.21 Million | 0.57x | N/A |
| 2017 | $225.23 Million | $505.28 Million | $38.11 Million | 0.45x | 5.91x |
| 2018 | $319.43 Million | $589.22 Million | $68.85 Million | 0.54x | 4.64x |
| 2019 | $410.10 Million | $619.59 Million | $46.28 Million | 0.66x | 8.86x |
| 2020 | $367.58 Million | $730.11 Million | $89.72 Million | 0.50x | 4.10x |
| 2021 | $251.05 Million | $904.99 Million | $113.96 Million | 0.28x | 2.20x |
| 2022 | $246.82 Million | $1.04 Billion | $130.66 Million | 0.24x | 1.89x |
| 2023 | $265.89 Million | $943.28 Million | -$49.98 Million | 0.28x | N/A |
| 2024 | $204.15 Million | $1.02 Billion | $814.39 Million | 0.20x | 0.25x |
| 2025 | $242.65 Million | $1.22 Billion | $222.31 Million | 0.20x | 1.09x |
Competitor Companies of OFSA3 by Market Capitalization
Companies near Ouro Fino Saúde Animal Participações S.A in the global market cap rankings as of October 30, 2026. See Ouro Fino Saúde Animal Participações S.A balance sheet quality to understand what proportion of total assets are financed by equity.
Key companies related to Ouro Fino Saúde Animal Participações S.A by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #515 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #536 globally with a market cap of $50.42 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #600 globally with a market cap of $45.38 Billion USD ( CN¥310.15 Billion CNY).
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #626 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #515 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #536 | GALDERMA GROUP AG | NYSE:GALDY | $50.42 Billion | $45.98 |
| #600 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $45.38 Billion | CN¥48.62 |
| #626 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €17.90 |
Market Capitalization of Ouro Fino Saúde Animal Participações S.A (2015–2026)
Market capitalization of Ouro Fino Saúde Animal Participações S.A from 2015 to today. Between 2015 and today, Ouro Fino Saúde Animal Participações S.A's market cap moved from $325.27 Million to $ 269.03 Million, with a yearly change of -1.66%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | R$269.03 Million | +10.87% |
| 2025 | R$242.65 Million | +18.86% |
| 2024 | R$204.15 Million | -23.22% |
| 2023 | R$265.89 Million | +7.73% |
| 2022 | R$246.82 Million | -1.69% |
| 2021 | R$251.05 Million | -31.70% |
| 2020 | R$367.58 Million | -10.37% |
| 2019 | R$410.10 Million | +28.39% |
| 2018 | R$319.43 Million | +41.82% |
| 2017 | R$225.23 Million | -13.90% |
| 2016 | R$261.59 Million | -19.58% |
| 2015 | R$325.27 Million | -- |
End of Day Market Cap According to Different Sources
On Oct 30th, 2026 the market cap of Ouro Fino Saúde Animal Participações S.A was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $269.03 Million USD |
| MoneyControl | $269.03 Million USD |
| MarketWatch | $269.03 Million USD |
| marketcap.company | $269.03 Million USD |
| Reuters | $269.03 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Ouro Fino Saúde Animal Participações S.A
Ouro Fino Saúde Animal Participações S.A., together with its subsidiaries, engages in the development, production, and sale of veterinary drugs, vaccines, and other products for production and companion animals primarily in Brazil. The company operates through three segments: Production Animals; Companion Animals; and International Operations. It manufactures and trades in medicines, including an… Read more